AFI CAPITAL PARTNERS LLC
AFI CAPITAL PARTNERS LLC is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US investing in cannabis, consumer-regulated-markets and biopharmaceutical.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- cannabis, consumer-regulated-markets, biopharmaceutical
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2018
Check size not disclosed
Thesis
AFI Capital Partners, established in 2018 and headquartered in Austin, Texas, is a growth equity firm specializing in early and growth-stage investments within hyper-growth markets, with a strong emphasis on the cannabis sector and its ancillary businesses, as well as adjacent consumer-regulated markets. Their investment thesis focuses on companies integral to the cannabis value chain, including cultivation, retail, and technology, and they also invest in biopharmaceutical research firms, including DEA-licensed entities. The firm targets opportunities across North America, particularly in states like California and Washington, and seeks to partner with companies demonstrating operational excellence and proven consumer demand. They have managed at least two venture capital funds, AFI Capital Partners Fund I (2018 vintage, Seattle) and AFI Capital Partners Fund II (Delaware). While specific AUM and check sizes are not disclosed, their investment scope spans from pre-seed to growth equity.
Common questions
Does AFI CAPITAL PARTNERS LLC invest at the Pre-seed stage?
Yes. AFI CAPITAL PARTNERS LLC lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
Where does AFI CAPITAL PARTNERS LLC invest?
AFI CAPITAL PARTNERS LLC invests in the US.